Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
2.095
-0.015 (-0.71%)
Oct 26, 2026, 9:34 AM EDT - Market open
PACB Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stephens | Stephens | Buy Maintains $1.5 → $2.5 | Buy | Maintains | $1.5 → $2.5 | +19.33% | Oct 23, 2026 |
| Barclays | Barclays | Sell Maintains $1.25 | Sell | Maintains | $1.25 | -40.33% | Oct 7, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 11, 2026 |
Unknown Analyst UBS No rating | UBS | Hold Initiates $1.5 → $1.35 | Hold | Initiates | $1.5 → $1.35 | -35.56% | Sep 9, 2026 |
| Piper Sandler | Piper Sandler | Hold Reiterates $2 | Hold | Reiterates | $2 | -4.53% | Aug 6, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $3 | Buy | Maintains | $3 | +43.20% | Aug 6, 2026 |